Effects of apolipoprotein a gene polymorphisms on lipoprotein (a) concentrations in Japanese

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 4, 1999, Pages 304-308

  Park, Hyun Young ^a,c   Nabika, Toru ^a,b   Notsu, Yoshitomo ^a   Kobayashi, Shotai ^a,b   Masuda, Junichi ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b Shimane Institute of Health Science   (Japan)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Apolipoprotein A phenotype; Japanese population; Linkage disequilibrium; Lipoprotein (a); Population genetics

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; JAPAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS A; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; JAPAN; LIPOPROTEIN(A); MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0032905969     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03033.x     Document Type: Article

References (28)

1. 1. Utermann G, Weber W. Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett. 1983; 154: 357-61.
2. 2. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986; 256: 2540-4.
3. 3. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Getto Jr AM. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 4: 758-65.
4. 4. Shintani S, Kikuchi S, Hamaguchi H, Shiigai T. High serum lipoprotein (a) levels are an independent risk factor for cerebral infarction. Stroke 1993; 24: 965-9.
5. 5. Desmarais RL, Sarembock IJ, Ayers CR, Vernon SM, Powers ER, Gimple LW. Elevated serum lipoprotein (a) is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation 1995; 91: 1403-9.
6. 6. Albers JJ, Adolphson JL, Hazzard WR. Radioimmunoassay of human plasma Lp(a) lipoprotein. J. Lipid Res. 1977; 18: 331-8.
7. 7. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma Lp(a) concentrations. J. Clin. Invest. 1992; 90: 52-60.
8. 8. DeMeester CA, Bu X, Gray RJ, Lusis AJ, Rotter JI. Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apoprotein (a) gene locus. Am. J. Hum. Genet. 1995; 56: 287-93.
9. 9. Sandholzer C, Hallman DM, Saha N et al. Effects of the apolipoprotein (a) size polymorphism on the lipoprotein (a) concentration in 7 ethnic groups. Hum. Gene. 1991; 86: 607-14.
10. 10. Kraft HG, Kochl S, Menzel HJ, Sandholzer C, Utermann G. The apolipoprotein (a) gene: A transcribed hypervariable locus controlling plasma lipoprotein (a) concentration. Hum. Genet. 1992; 90: 220-30.
11. 11. Cohen JC, Chiesa G, Hobbs HH. Sequence polymorphisms in the apolipoprotein (a) gene. J. Clin. Invest. 1993; 91: 1630-6.
12. 12. Kraft HG, Haibach C, Lingenhel A et al. Sequence polymorphism in kringle IV 37 in linkage disequilibrium with the apoprotein (a) size polymorphism. Hum. Genet. 1995; 95: 275-82.
13. 13. Ichinose A, Kuriyama M. Detection of polymorphisms in the 5′-flanking region of the gene for apolipoprotein (a). Biochem. Biophys. Res. Commun. 1995; 209: 372-8.
14. 14. Wade DP, Clarke JG, Lindahl GE et al. 5′ control regions of the apolipoprotein (a) gene and members of the related plasminogen gene family. Proc. Natl Acad. Sci. USA 1993; 90: 1369-73.
15. 15. Trommsdorff M, Kochl S, Lingenhel A et al. A pentanucleotide repeat polymorphism in the 5′ control region of the apolipoprotein (a) gene is associated with lipoprotein (a) plasma concentration in Caucasians. J. Clin. Invest. 1995; 96: 150-7.
16. 16. Amemiya H, Arinami T, Kikuchi S et al. Apolipoprotein (a) size and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease. Atherosclerosis 1996; 123: 181-91.
17. 17. Suzuki K, Kuriyama M, Saito T, Ichinose A. Plasma lipoprotein (a) levels and expression of the apolipoprotein (a) gene are dependent on the nucleotide polymorphisms in its 5′-flanking region. J. Clin. Invest. 1997; 99: 1361-6.
18. 18. Kraft HG, Windegger M, Menzel HJ, Utermann G. Significant impact on the +93 C/T polymorphism in the apolipoprotein (a) gene on Lp(a) concentrations in Africans but not in Caucasians: Confounding effect of linkage disequilibrium. Hum. Mol. Genet. 1998; 7: 257-64.
19. 19. Schriewer H, Assmann G, Sandkamp M, Schulte H. The relationship of lipoprotein (a) to risk factor of coronary heart disease: Initial results of the prospective epidemiological study of company employees in Westfalia. J. Clin. Chem. Clin. Biochem. 1984; 22: 591-6.
20. 20. Kim CJ, Min YK, Ryu WS, Kwak JW, Ryoo UH. Effect of hormone replacement therapy on lipoprotein (a) and lipid levels in post-menopausal women. Influence of various progestogens and duration of therapy. Arch. Intern. Med. 1996; 156: 1693-700.
21. 21. Abe A, Takashima M. Number of apolipoprotein (a) kringle IV repeats and mobility of isoforms in PAGE. Jpn. J. Clin. Pathol. 1998; 46: 283-8.
22. 22. Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA. Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes. Nature 1986; 324: 163-6.
23. 23. Xie X, Ott J. Testing linkage disequilibrium between a disease gene and marker loci. Am. J. Hum. Genet. 1993; 53: 1107 (Abstract).
24. 24. Hill WG. Estimation of linkage disequilibrium in randomly mating populations. Heredity 1974; 33: 229-39.
25. 25. Thompson EA, Deeb S, Walker D, Motulsky AG. The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am. J. Hum. Genet. 1988; 42: 113-24.
26. 26. Zysow BR, Lindahl GE, Wade DP, Knight BL, Lawn RM. C/T polymorphism in the 5′ untranslated region of the apolipoprotein (a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler. Thromb. Vasc. Biol. 1995; 15: 58-64.
27. 27. Mooser V, Mancini FP, Bopp S et al. Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum. Mol. Genet. 1995; 4: 173-81.
28. 28. Gaw A, Boerwinkle E, Cohen JC, Hobbs HH. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. J. Clin. Invest. 1994; 93: 2526-34.